drugset / Trial / NCT03548129

the Use of Fosfomycin as a Single Dose Oral Treatment of Asymptomatic Bacteriuria

NCT03548129

Phase 2 Unknown 88 enrolled Ain Shams University
RandomizedParallel-groupSingle-blindTreatment

Summary

Urinary tract infections (UTIs) are the most commonly occurring bacterial infections in women, Asymptomatic bacteriuria (AB) is a common complication during pregnancy, with a prevalence of 2-10%. It has been associated with a greater incidence of symptomatic urinary tract infection (UTI), as well as foetal and obstetric complications. Appropriate treatment reduces the incidence of UTI by 80-90%, as well as the risk of a premature birth and low-birth-weight baby Fosfomycin trometamol (Monuril) is approved in numerous countries worldwide, including various European countries and the USA, mainly for the treatment of uncomplicated UTIs

Timeline

Start
2016-07
Primary completion
2018-07
Completion
2018-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fosfomycin Small molecule 3 g Oral